tiprankstipranks
Trending News
More News >
Medicinova (MNOV)
:MNOV
US Market
Advertisement

Medicinova (MNOV) Stock Forecast & Price Target

Compare
312 Followers
See the Price Targets and Ratings of:

MNOV Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Medicinova
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MNOV Stock 12 Month Forecast

There Are No Analyst Ratings for MNOV In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MNOV Financial Forecast

MNOV Earnings Forecast

Next quarter’s earnings estimate for MNOV is -$0.07 with a range of -$0.07 to -$0.07. The previous quarter’s EPS was -$0.15. MNOV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.
Next quarter’s earnings estimate for MNOV is -$0.07 with a range of -$0.07 to -$0.07. The previous quarter’s EPS was -$0.15. MNOV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.

MNOV Sales Forecast

Next quarter’s sales forecast for MNOV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. MNOV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.
Next quarter’s sales forecast for MNOV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. MNOV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
B. Riley Securities Analyst forecast on MNOV
B. Riley Securities
B. Riley Securities
$6$5
Buy
313.22%
Upside
Reiterated
06/16/25
MediciNova price target lowered to $5 from $6 at B. RileyMediciNova price target lowered to $5 from $6 at B. Riley
D. Boral Capital Analyst forecast on MNOV
D. Boral Capital
D. Boral Capital
$9
Buy
643.80%
Upside
Initiated
12/02/24
MediciNova initiated with a Buy at D. Boral CapitalMediciNova initiated with a Buy at D. Boral Capital
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
B. Riley Securities Analyst forecast on MNOV
B. Riley Securities
B. Riley Securities
$6$5
Buy
313.22%
Upside
Reiterated
06/16/25
MediciNova price target lowered to $5 from $6 at B. RileyMediciNova price target lowered to $5 from $6 at B. Riley
D. Boral Capital Analyst forecast on MNOV
D. Boral Capital
D. Boral Capital
$9
Buy
643.80%
Upside
Initiated
12/02/24
MediciNova initiated with a Buy at D. Boral CapitalMediciNova initiated with a Buy at D. Boral Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medicinova

1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-8.20%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -8.20% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.00%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -6.00% per trade.
1 Year
Kalpit PatelB. Riley Securities
Success Rate
0/1 ratings generated profit
0%
Average Return
-10.50%
reiterated a buy rating 5 months ago
Copying Kalpit Patel's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -10.50% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-10.50%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -10.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MNOV Analyst Recommendation Trends

Rating
Jun 22
Nov 22
Dec 22
Dec 24
Jun 25
Strong Buy
5
3
3
2
3
Buy
0
0
0
0
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
4
3
3
In the current month, MNOV has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MNOV average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

MNOV Stock Forecast FAQ

What is MNOV’s average 12-month price target, according to analysts?
Currently, no data Available
What is MNOV’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MNOV, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MNOV a Buy, Sell or Hold?
      Currently, no data Available
      What is Medicinova’s price target?
      Currently, no data Available
      What do analysts say about Medicinova?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MNOV?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis